Gainers
Applied Blockchain, Inc. (NASDAQ: APLD) shares climbed 100% to close at $2.12 on Tuesday after the company reported a 200-megawatt five-year hosting contract with Marathon Digital Holdings and raised its Q4 revenue forecast.
Gainers
Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical study of REVTx-99b for the treatment of allergic rhinitis.
Gainers
Travere Therapeutics (NASDAQ:TVTX) stock increased by 16.5% to $28.87 during Friday's after-market session. The market value of their outstanding shares is at $1.8 billion.
Cyclacel Pharmaceuticals (NASDAQ:CYCC) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Cyclacel Pharmaceuticals (NASDAQ:CYCC) reported quarterly losses of $(0.42) per share which beat the analyst consensus estimate of $(0.68) by 38.24 percent. This is a 16 percent increase over losses of $(0.50) per share